Keyphrases
Cholinergic Anti-inflammatory Pathway
100%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Plasmacytoid Dendritic Cells
100%
Colitis
100%
Ulcerative Colitis
80%
Oxazolone-induced Colitis
80%
Colon
60%
Nicotine
60%
Methyllycaconitine
40%
CCL21
40%
Oxazolone
40%
Isolated Lymphoid Follicles
40%
Immune Cells
20%
Therapeutic Effect
20%
Therapeutic Potential
20%
Stimulants
20%
Anti-inflammatory Effect
20%
Balb C Mice
20%
Th2 Cytokines
20%
2-Deoxy-d-glucose (2-DG)
20%
Nerve Fibers
20%
Pathophysiological Roles
20%
Bone Marrow Cells
20%
Rac1
20%
Caspase-3 Inhibitor
20%
Cholinergic Pathway
20%
Ulcerative Colitis Patient
20%
Chronic Inflammatory Bowel Disease
20%
Cholinergic Nerves
20%
Innovative Therapies
20%
JAK2 Inhibitor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Colitis
100%
Cholinergic Receptor Stimulating Agent
100%
Oxazolone
100%
Nicotinic Receptor
83%
Ulcerative Colitis
83%
Methyllycaconitine
33%
Glucose
16%
Cytokine
16%
Therapeutic Effect
16%
Antiinflammatory Activity
16%
Inflammatory Bowel Disease
16%
Bagg Albino Mouse
16%
Caspase 3 Inhibitor
16%
N Benzyl 2 Cyano 3 (3,4 Dihydroxyphenyl)acrylamide
16%
Janus Kinase 2 Inhibitor
16%